How to Buy Structure Therapeutics Stock
Structure Therapeutics Inc
Structure Therapeutics Inc. , a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.
Structure Therapeutics stock last closed at $64.94, up 3.99% from the previous day, and has increased 116.68% in one year. It has overperformed other stocks in the Biotechnology industry by 1.57 percentage points. Structure Therapeutics stock is currently +391.23% from its 52-week low of $13.22, and -31.57% from its 52-week high of $94.90.
As of Dec 19, 2025, there are 182.03M shares of GPCR outstanding. The market value of GPCR is $3.94B. In the past 24 hours, 1.82M GPCR shares were traded.
How to Buy Structure Therapeutics Stock
Not sure how to invest in Structure Therapeutics stock? Here's how.
- Choose where to buy Structure Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Structure Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your payment method and add your info.
- Analyze Structure Therapeutics stock: The Structure Therapeutics ticker symbol is GPCR. Is Structure Therapeutics stock a good investment? Should you buy shares of GPCR? How do GPCR's underlying business fundamentals look? Do top analysts think Structure Therapeutics is a good buy? Why has GPCR's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if GPCR is a good stock to buy).
- Place your GPCR buy order: Decide if you will purchase GPCR shares at the current market price or use a limit order to purchase GPCR shares at a specific price.
- Get key alerts regarding your GPCR position: Create a watchlist to key updates about your position in Structure Therapeutics shares.
Step 1: Choose where to buy Structure Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy GPCR shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in GPCR stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've created your account on the best stock market app for beginners, you need to deposit funds:
Check out the tutorial below for more details transferring funds into your brokerage account.
Step 4: Analyze Structure Therapeutics stock
After you have chosen the best place to buy Structure Therapeutics stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.
Structure Therapeutics stock data
Structure Therapeutics Overview
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on GPCR's stock page.
Is GPCR stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge GPCR's intrinsic value.
Using relative valuations ratios:
- GPCR could be undervalued based on its P/B ratio of 5.11x, relative to Biotechnology industry P/B ratio of 5.27x
You can do additional valuation research on GPCR's stock here.
A look at GPCR Cashflows and Balance Sheet
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the GPCR balance sheet.
- GPCR has a low debt to equity ratio of 0.08.
- There are more short-term assets than long-term liabilities on the GPCR balance sheet.
- GPCR has $799.04M in cash and short term investments. This is sufficient to cover its annual cash burn of $196.38M.
- GPCR has cash burn of 196384000. It has enough cash and short-term investments to cover this for at least one year.
Do Wall Street analysts think it's a good time to buy GPCR stock
Out of 9 Wall Street analysts who monitor GPCR, the consensus analyst rating on GPCR is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest GPCR Analyst Upgrades/Downgrades
Annabel Samimy, a top 8% analyst from Stifel Nicolaus maintains GPCR with a strong buy rating and raises their GPCR price target from $50.00 to $90.00, on Dec 9, 2025.
Stifel Nicolaus's Annabel Samimy raised their price target on Structure Therapeutics (NASDAQ: GPCR) by 80% from $50 to $90 on 2025/12/09. The analyst maintained their Strong Buy rating on the stock.
Following the confirmation of aleniglipron's dose-dependent efficacy and noteworthy improvement in safety profile in both the ACCESS and ACCESS-II trials, Samimy said they hiked their price target.
According to the analyst, Structure Therapeutics "now has a viable and versatile small-molecule offering for independent development or future partnership."
Kaveri Pohlman, a bottom 7% analyst from Clear Street maintains GPCR with a strong buy rating and raises their GPCR price target from $61.00 to $99.00, on Dec 9, 2025.
Seamus Fernandez, a top 2% analyst from Guggenheim maintains GPCR with a strong buy rating and lowers their GPCR price target from $92.00 to $90.00, on Aug 7, 2025.
Prakhar Agrawal, a top 20% analyst from Cantor Fitzgerald reiterates GPCR with a strong buy rating and maintains their GPCR price target from $65.00 to $65.00, on Jun 23, 2025.
You can dig deeper into what analysts are projecting on the Structure Therapeutics stock forecast page.
GPCR Momentum
What are GPCR insiders up to?
In the past 12 months, insiders at GPCR have sold more shares than they have bought.
Crespo Blas Coll, CHIEF MEDICAL OFFICER of GPCR, was the latest GPCR insider to sell. They sold $62,764.76 worth of GPCR shares on Sep 18, 2025.
Get more info about who owns GPCR stock here.
Does GPCR provide a stable income stream?
No, Structure Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your GPCR buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount limit, use a limit order.
Press the Open button and your broker will execute the order.
If you need more info about investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your GPCR position
Now that you own some GPCR shares, you'll want to stay up-to-date on your new shares.
Create a watchlist to track the most important metrics related to your GPCR stock.
GPCR Feed
How to Buy Stock in Structure Therapeutics
To summarize, here are the 6 steps you need to take to buy Structure Therapeutics stock right now:
- Choose where to buy Structure Therapeutics stock
- Sign up for your brokerage account
- Fund your investment account
- Analyze Structure Therapeutics stock
- Place your GPCR buy order
- Get key alerts regarding your GPCR position
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Structure Therapeutics, create your watchlist below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.